As we age, our lips and the surrounding area tend to lose its supply and defined structure. Juvéderm Volbella® XC is a revolutionary new lip filler from Allergan — the maker of Juvederm® and Botox® — that increases fullness and smooths the lines and wrinkles above, below and on the lips for a more defined appearance.
Juvéderm Volbella® XC is an injectable gel made from a hyaluronic acid (a natural sugar found in skin) that utilizes Vycross technology to fill in lip lines and wrinkles.
Juvéderm Volbella® XC is injected into the lip area with an ultra-fine needle, instantly improving lip contour, softening vertical lines (smoker’s lines), and achieving symmetry — all in a single comfortable treatment.
Because Juvéderm Volbella® XC contains Lidocaine, a local anesthetic, the treatment process allows for very minimal discomfort.
Areas Of Concern:
During your initial consultation, Dr. Patel will thoroughly discuss your goals and expectations, including possible risks and the best way to prepare for your treatment. If you are interested in learning more about how Juvéderm Volbella® XC at Clarity Medical Spa in San Jose can give you fuller looking lips, give us a call at (408) 669-4070.
Juvéderm Volbella® XC injectable gel is for injection into the lips for lip augmentation and for correction of perioral lines, often called “lipstick lines” in adults over the age of 21.
You will see immediate results from your Juvéderm Volbella® XC treatments.
Results from Juvéderm Volbella® XC treatments can last up to one year.
Juvéderm Volbella® XC is a crystal-clear gel that is injected directly into and around the lips using an ultra-fine needle to temporarily plump the lips for lip augmentation and to smooth the appearance of lines around the mouth. The lidocaine gel improves the comfort of the injection by reducing sensitivity to pain.
The most common side effects included temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects were mild or moderate (uncomfortable) and generally lasted 30 days or less.